openPR Logo
Press release

Autoinjectors Market Outlook: Competitor Insights and Market Forecast Through 2024-2031 | SHL Medical AG, Amgen Inc., Owen Mumford Ltd., Ypsomed AG

06-25-2025 11:22 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Autoinjectors Market - DataM Intelligence

Autoinjectors Market - DataM Intelligence

Autoinjectors Market reached US$ 10.37 billion in 2024 and is expected to reach US$ 39.84 billion by 2033, growing at a CAGR of 17.2% during the forecast period 2025-2033

The Autoinjectors Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that help clients navigate complex market dynamics, drive strategic growth, and seize new opportunities in an ever-evolving global landscape.

Download your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/autoinjectors-market?sg

Autoinjectors Market Landscape Analysis :

Auto-injectors are medical devices designed for the self-administration of pre-measured medications, primarily used in emergencies or for managing chronic conditions. These devices typically feature a spring-activated mechanism, enabling users to deliver an injection quickly and easily without needing to manually press a plunger. This user-friendly design ensures that even individuals without medical training can operate them effectively.

The rapid drug delivery capability of auto-injectors is especially critical in urgent scenarios such as anaphylactic reactions, where immediate treatment can prevent life-threatening complications.

The increasing number of regulatory approvals and new product launches is a key driver of growth in the auto-injector market. For example, in March 2023, Coherus Biosciences received FDA approval for a single-dose, prefilled auto-injector version of its pegfilgrastim biosimilar, intended for the treatment and prevention of febrile neutropenia, a common side effect of chemotherapy. This new device, marketed as Udenyca, allows patients to receive their dose one day after chemotherapy, thereby reducing the risk of developing febrile neutropenia. The injector is activated by simply pressing it against the skin, ensuring quick and accurate delivery of the medication.

Autoinjectors Market: Shifting Industry Trends and Market Potential

Rising Regulatory Approvals and Product Launches Fuel Auto-Injector Market Growth

The increasing number of regulatory approvals and product launches is emerging as a key driver of growth in the global auto-injector market. As the demand for self-administration medical devices continues to rise, agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are adapting their regulatory pathways to support the faster approval of innovative auto-injector technologies.

This shift is vital as it not only enhances patient access to essential therapies but also boosts confidence among healthcare providers and patients in the safety, reliability, and effectiveness of these devices.

Several recent approvals and product introductions underscore this momentum. For example, in June 2023, Halozyme Therapeutics, Inc. announced that argenx received FDA approval for VYVGART Hytrulo, a subcutaneous injection using Halozyme's ENHANZE® technology. The treatment is intended for adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive. This approval reflects the growing trust in auto-injector platforms for delivering targeted therapies in a more convenient and patient-friendly manner.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/autoinjectors-market?sg

Strategic Players Driving the Autoinjectors Market Forward: Eli Lilly and Company, SHL Medical AG, Amgen Inc., Owen Mumford Ltd., Ypsomed AG, Teva Pharmaceutical Industries Ltd., Biogen, Mylan Inc., Pfizer Inc., and Sanofi.

Research Methodology:

The global Autoinjectors Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Segment Covered in the Autoinjectors Market:

By Type (Disposable Autoinjectors, Reusable Autoinjectors)

By Technology (Manual Autoinjectors, Automated Autoinjectors)

By Route of Administration (Intramuscular, Intravenous and Subcutaneous)

By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Others)

By End-User (Home Care Setting, Hospitals, Ambulatory Surgical Centers)

By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sg

Regional Analysis for Autoinjectors Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Most Frequently Asked Questions in the Autoinjectors Market Research Industry:

➠ Who leads the Autoinjectors industry and what's their competitive positioning regarding capacity, performance, and profitability?

➠ What growth opportunities and market challenges do Autoinjectors market vendors face?

➠ Which segments show the highest growth potential and market share distribution?

➠ What factors are driving or limiting Autoinjectors market growth?

➠ What are the dominant sales and distribution strategies in the Autoinjectors industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Autoinjectors Market Outlook: Competitor Insights and Market Forecast Through 2024-2031 | SHL Medical AG, Amgen Inc., Owen Mumford Ltd., Ypsomed AG here

News-ID: 4081184 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Harnessing Solar Panel Market Booms Investments Surge Globally To 2031 | Shunfeng International Clean Energy Limited, KyoCera Solar, Yingli Solar, Canadian Solar
Harnessing Solar Panel Market Booms Investments Surge Globally To 2031 | Shunfen …
Market Size and Growth ✦ The market was reflecting strong, sustained growth US$ 165.2 million in 2022 and is expected to reach US$ 642.3 million by 2031 CAGR of 18.5% during the forecasting period (2024-2031). ✦ The driving force behind this expansion is a combination of surging global demand, technological advancements, and significant investments in new infrastructure projects. Mergers and Acquisition Mergers and acquisitions activity for solar projects and companies has increased in
Lithium-ion Battery Recycling Market Booms To 2031 | American Manganese Inc., Retriev Technologies, Li-Cycle Corp, SNAM
Lithium-ion Battery Recycling Market Booms To 2031 | American Manganese Inc., Re …
Market Size and Growth ✦ The market was reflecting strong, sustained growth USD 6.1 billion in 2022 and is expected to reach USD 20.4 billion by 2031, CAGR of 22.3% during the forecasting period (2024-2031). ✦ The driving force behind this expansion is a combination of surging global demand, technological advancements, and significant investments in new infrastructure projects. Mergers and Acquisition The Li-ion battery recycling market is growing rapidly with new partnerships, supply
Renewable Energy Market Booms USD 2.0 Trillion by 2031 | Ørsted A/S, First Solar, Adani Green Energy, Tata Power, NextEra Energy
Renewable Energy Market Booms USD 2.0 Trillion by 2031 | Ørsted A/S, First Sola …
Market Size and Growth ✦ The market was reflecting strong, sustained growth USD 1.1 trillion in 2022 and is expected to reach USD 2.0 trillion by 2031 by 2031 CAGR of 8.4% during the forecasting period (2024-2031). ✦ The driving force behind this expansion is a combination of surging global demand, technological advancements, and significant investments in new infrastructure projects. Mergers and Acquisition The OCU Group acquired McCormack Drilling to enhance its trenchless
Wind Turbine Market Analysis, Trends, Challenges & Competitive Landscape Report To 2031
Wind Turbine Market Analysis, Trends, Challenges & Competitive Landscape Report …
Market Size and Growth ✦ The market was reflecting strong, sustained growth CAGR of 6% during the forecasting period (2024-2031). ✦ The driving force behind this expansion is a combination of surging global demand, technological advancements, and significant investments in new infrastructure projects. Mergers and Acquisition A key trend is the development of next-generation wind turbines, such as Envision Energy's two-blade onshore model, which has demonstrated high efficiency and stability. TPI Composites, a major

All 5 Releases


More Releases for Autoinjectors

Elevated Prevalence Of Chronic Diseases Sparks Growth In The Autoinjectors Marke …
The Autoinjectors Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Autoinjectors Market? In recent times, the autoinjectors market has experienced substantial growth. Projections indicate that it will expand from a valuation of $3.7 billion in 2024 to $4.55 billion
Automated Autoinjectors Market
The "Automated Autoinjectors Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Automated Autoinjectors Market, 2024-2031 Verified Market Research's most recent report, "Automated Autoinjectors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination
Autoinjectors Market worth $ 226.37 Million by 2030
Insightace Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Autoinjectors Market- by Type (Disposable Autoinjectors and Reusable Autoinjectors) Applications (Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis and Others), End-User (Home care settings and Hospitals & Clinics), Trends, Industry Competition Analysis, Revenue and Forecast To 2030." Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1234 According to the latest research by Insightace Analytics, the global autoinjectors market was valued at US$ 47.13 Million
Reusable Autoinjectors Market Size - Forecast to 2026
As per the research conducted by GME, the Global Reusable Autoinjectors Market is projected to grow at a CAGR value of 11.7% during the forecast period [2021 to 2026]. Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Reusable Autoinjectors Market - Forecast to 2026” https://www.globalmarketestimates.com/market-report/reusable-autoinjectors-market-3325 By Dose (Fixed and Variable), By Technology (Smart Autoinjectors, Conventional Autoinjectors) By Application (Anaphylaxis, Rheumatoid Arthritis, Multiple
Autoinjectors Market 2022 Trends and Review
ReportsWeb.com has announced the addition of the “Global Autoinjectors Market Research Report 2017” The report focuses on global major leading players with information such as company profiles, product picture and specification. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD) , market share and growth rate of Autoinjectors in these regions, from 2012 to 2022 (forecast) , covering North America, Europe, China, Japan, Southeast Asia
Autoinjectors Market 2016: Disposable Autoinjectors, Reusable Autoinjectors
Autoinjector is a medical device used to dispense a single dose of a drug, particularly, life-saving drugs. These Autoinjectors are usually spring-loaded syringes that are particularly designed for easy and safe administration of the drugs. The injectable drug delivery method is a technology driven market and has experienced a paradigm shift. The traditionally used self-injection devices, which were merely used for delivering human growth hormones and insulin are currently replaced